Detecting and treating per- and polyfluoroalkyl substances (PFAS) in Canadian water systems

检测和处理加拿大水系统中的全氟烷基物质和多氟烷基物质 (PFAS)

基本信息

  • 批准号:
    571095-2021
  • 负责人:
  • 金额:
    $ 26.07万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Alliance Grants
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

On 24 April 2021, the Canadian Federal government issued a "Notice of intent to address the broad class of per- and polyfluoroalkyl substances (PFAS)". PFAS are an emerging class of environmental contaminants, which have unknown human health effects and for which traditional methods treatment are ineffective. The United States Environmental Protection Agency lists more than 4,700 PFAS molecules in their toxicity database, but standard analytical methods have been published for only a handful of these species (e.g., the EPA has reported methods for the determination of 18 PFAS in drinking water). Professors Hopkins (University of Waterloo) and Berruti (Western University) have partnered with USP Technologies, Brown and Caldwell, the Ontario Clean Water Agency, and seven regional water supply systems in Ontario to address the presence of and treatment of PFAS in water supplies. The partnering facilities provide water and wastewater services to more than 2.5 million Canadians. Prof. Hopkins will direct research concerned with detecting trace amounts of PFAS in water and biosolid samples using ion mobility spectrometry and mass spectrometry. Following data acquisition, Hopkins will oversee the development of machine learning models to predict the physicochemical properties of PFAS and the transformation products yielded by the treatment processes. Prof. Berruti will direct research concerned with destruction of PFAS in biosolids via pyrolysis, and in water via VUV treatment in collaboration with Dr. Domenico Santoro from USP Technologies Inc. This research will determine which PFAS are present in Ontario waters, determine the chemical and physical processes underpinning treatment technologies, and provide key information to inform Canadian water systems of potential PFAS contaminants and treatment options.
2021年4月24日,加拿大联邦政府发布了一份“关于处理全氟烷基和多氟烷基物质(PFAS)大类的意向书”。全氟磺酸钠是一类新兴的环境污染物,对人类健康的影响尚不清楚,传统的治疗方法对其无效。美国环境保护署在其毒性数据库中列出了4700多种PFAS分子,但仅公布了其中少数几种的标准分析方法(例如,环境保护署报告了饮用水中18种PFAS的测定方法)。霍普金斯教授(滑铁卢大学)和Berruti教授(西部大学)与USP技术公司、布朗和考德威尔公司、安大略省清洁水局以及安大略省的七个地区供水系统合作,解决供水中PFAS的存在和处理问题。这些合作设施为250多万加拿大人提供水和污水处理服务。霍普金斯教授将指导有关使用离子迁移率光谱法和质谱法检测水和生物固体样品中痕量PFAS的研究。在获取数据后,Hopkins将监督机器学习模型的开发,以预测PFAS的物理化学性质以及处理过程产生的转化产物。Berruti教授将与USP Technologies Inc.的Domenico Santoro博士合作,指导有关通过热解和VUV处理在生物固体中破坏PFAS的研究。这项研究将确定安大略省水域中存在哪些PFAS,确定基础处理技术的化学和物理过程,并提供关键信息,告知加拿大水系统潜在的PFAS污染物和处理方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hopkins, ScottWS其他文献

Hopkins, ScottWS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Understanding and treating neurogenetic conditions related to the Kennedy pathway
了解和治疗与肯尼迪通路相关的神经遗传疾病
  • 批准号:
    MR/Y014251/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Research Grant
AMPQuest - Journeying to new horizons in treating drug-resistant infections.
AMPQuest - 迈向治疗耐药感染的新视野。
  • 批准号:
    BB/Y514019/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Research Grant
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
  • 批准号:
    MR/Y014901/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Research Grant
ICF - Evaluate the potential of AstraZeneca's sialic acid tag technology for treating influenza viruses with Fc molecules
ICF - 评估阿斯利康唾液酸标签技术用 Fc 分子治疗流感病毒的潜力
  • 批准号:
    MR/Y503459/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Research Grant
A Novel Ruthenium Antimicrobial Platform Technology - Preventing and Treating Multi-Drug Resistant Infections
新型钌抗菌平台技术——预防和治疗多重耐药感染
  • 批准号:
    10050214
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant for R&D
Targeting Ryanodine Receptor 2 for Treating Neonatal Hypoxic-ischemic Brain Injury (HIBI)
靶向 Ryanodine 受体 2 治疗新生儿缺氧缺血性脑损伤 (HIBI)
  • 批准号:
    488816
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Operating Grants
Investigating the efficacy and safety profiles of Bimekizumab in treating moderate-to-severe plaque psoriasis: A Canadian retrospective study
调查 Bimekizumab 治疗中重度斑块状银屑病的疗效和安全性:加拿大回顾性研究
  • 批准号:
    484723
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Studentship Programs
Treating Auditory Hypersensitivity in Autistic Children using Virtual Ambisonics
使用虚拟高保真音响治疗自闭症儿童的听觉过敏
  • 批准号:
    2887563
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Studentship
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose
经皮膈神经刺激治疗阿片类药物过量
  • 批准号:
    10681111
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
  • 批准号:
    10819329
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了